Main Newsletter
Mastery Series
Therapy Series
 
Bookmark and Share | Print Article | Items for the Week Previous | All Articles This Week | Next
This article originally posted and appeared in  Issue 507CardiovascularCulturally Aware Care

Diabetes Linked to Improved Survival in Critically Ill Patients

Consistent with prior reports, but still surprising, diabetes does not worsen hospital mortality in critically ill patients, researchers say. In fact, diabetes is often associated with improved survival....

Advertisement

The analysis covered more than 1.5 million subjects in a retrospective cohort and more than 36,000 subjects in a prospective cohort.

Senior author Dr. Ivor S. Douglas wrote, "Our observations robustly correlate with those of other investigators in the field.... Mortality was lower in diabetes for all ... diagnoses except acute myocardial infarction -- consistent with smaller studies."

In the January 10th issue of Critical Care Medicine, Dr. Douglas of the University of Colorado, Denver, and colleagues report that in the larger retrospective cohort, patients with a history of diabetes had a lower risk of in-hospital mortality compared to nondiabetics. Before adjustment, the odds ratio was 0.90; after adjustment, it was 0.75.

In the prospective cohort, after adjustment for age and severity of illness, the odds ratio for mortality was 0.88 in the diabetes group.

In the retrospective dataset, diabetic patients in all severity-of-illness categories had lower hospital mortality compared to nondiabetics. In the prospective dataset, diabetic patients with extreme severity of illness had decreased age-adjusted hospital mortality.

"The surprising finding highlights that despite decades of investigation we continue to have a limited understanding of the pathophysiological modifying effects of diabetes in critical illness," Dr. Douglas said. "Our data suggest that there is a potential protective effect in diabetics of hyperglycemia but relative intolerance of hypoglycemia."

He continued, "Importantly, there was a particularly detrimental effect of acute hyperglycemia in nondiabetic patients which may account for the significant difference in mortality we found between diabetic and nondiabetic patients in critical illness."

Dr. Douglas and his coauthors acknowledge that their findings "may seem counterintuitive." But they also point out that "preexisting diabetes is not a chronic health parameter in the calculation of APACHE III or IV," because it did not independently predict mortality when those scores were derived.

Now, the researchers conclude, it's time "to evaluate potential mechanisms for this association that might be therapeutically exploitable."

Crit Care Med 2010;38:16-24.
Advertisement


 

Bookmark and Share | Print | Category | Home

This article originally posted 02 February, 2010 and appeared in  Issue 507CardiovascularCulturally Aware Care

Past five issues: Diabetes Clinical Mastery Series Issue 212 | GLP-1 Special Editions October 2014 | Issue 752 | SGLT-2 Inhibitors Special Edition October 2014 | Diabetes Clinical Mastery Series Issue 211 |

2014 Most Popular Articles:

For Your Patients: Why Daily Movement Improves Your Brain Health (Part 2): Brain Hormone Changes
Posted October 17, 2014
Two Positive Phase 3 Trials for ITCA 650, a GLP-1 Agonist, in Type 2 Diabetes
Posted October 10, 2014
Adding an SGLT2 to Insulin Improved Control
Posted October 17, 2014
New GLP-1 Receptor Agonist as an Alternative to Insulin Glargine?
Posted October 10, 2014
Vitamin D and Type 2 Diabetes Risk
Posted October 17, 2014
Best Insulin Regimen for Type 1's
Posted October 10, 2014
EASD: Insulin Pumps Lower Mortality Rate 29% Compared to Multiple Injections in T1DM
Posted October 03, 2014
Handbook of Diabetes, 4th Ed., Excerpt #13: Control and Complications
Posted October 13, 2014
Non-Caloric Artificial Sweeteners May Induce Glucose Intolerance
Posted October 10, 2014
FDA Approves Once-Weekly GLP-1 Diabetes Treatment Regimen for T2DM
Posted September 25, 2014


Browse by Feature Writer & Article Category.
A. Lee Dellon, MD | Aaron I. Vinik, MD, PhD, FCP, MACP | Beverly Price | Charles W Martin, DD | Derek Lowe, PhD | Dr. Brian Jakes, Jr. | Dr. Fred Pescatore | Dr. Tom Burke, Ph.D | Eric S. Freedland | Evan D. Rosen | Ginger Kanzer-Lewis | Greg Milliger | Kristina Sandstedt | Laura Plunkett | Leonard Lipson, M.A. | Louis H. Philipson | Maria Emanuel Ryan, DDS, PhD | Marilyn Porter, RD, CDE | Melissa Diane Smith | Michael R. Cohen, RPh, MS, ScD, FASHP | Paul Chous, M.A., OD | Philip A. Wood PhD | R. Keith Campbell, Professor, B.Pharm, MBA, CDE | Richard K. Bernstein, MD | Sheri R. Colberg PhD | Sherri Shafer | Stanley Schwartz, MD, FACP, FACE | Steve Pohlit | Steven V. Edelman, M.D. | Timothy S. Hollingshead |

Cast Your Vote
Are your patients getting enough glucose strips to manage their diabetes?
CME/CE of the Week

Diabetes in Pregnancy
Lois Jovanovic, MD

Category: CDE

CE Credits: 75

 



Search Articles On Diabetes In Control